课题基金 / 基金详情

MOLECULAR BIOLOGY OF HEPATITIS C VIRUS

MOLECULAR BIOLOGY OF HEPATITIS C VIRUS
丙型肝炎病毒的分子生物学
批准号:
2566812
负责人:
R H PURCELL
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:

项目摘要

项目成果

R H PURCELL的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Hepatitis C virus (HCV) appears to be the major current etiological agent of transfusion-related non-A, non-B hepatitis. The HCV genome is a linear, positive-strand RNA molecule of approximately 9,500 nucleotides and encodes a polyprotein of about 3,000 amino acids. Several stretches of amino acids in the HCV polyprotein share significant similarity with flavivirus and pestivirus proteins. Therefore, HCV is considered to be distantly related to these virus groups. The goal of this project is to increase our understanding of the molecular biology of this important human pathogen. Extensive sequence analysis has been performed on the 5' noncoding (NC) region, core, envelope 1 and hypervariable region (HVR1) of envelope 2 genes of over forty strains of HCV. In addition, neutralization assays, based upon blocking of attachment of virus to susceptible cells in vitro and prevention of infection of chimpanzees in vivo, have been developed and are being characterized for specificity and sensitivity. Prototype strains of the various genotypes of HCV, including some of those discovered in this laboratory, are being biologically amplified in chimpanzees and further characterized. Pools of virus-containing plasma will be packaged and distributed for further characterization, and used as challenge inocula in studies of passive and active immunoprophylaxis, etc.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
STUDIES OF ACQUIRED IMMUNE DEFICIENCY SYNDROME
SECOND AND THIRD-GENERATION HEPATITIS B VACCINES
WOODCHUCK HEPATITIS VIRUS
SECOND AND THIRD-GENERATION HEPATITIS B VACCINES
海外基金